Clover Health Investments Corp’s recent filing unveils that its Director Garipalli Vivek acquired Company’s shares for reported $1.0 million on Jun 17 ’24. In the deal valued at $1.14 per share,877,567 shares were bought. As a result of this transaction, Garipalli Vivek now holds 877,567 shares worth roughly $1.55 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Loengard Anna U bought 10,000 shares, generating $9,300 in total proceeds. Upon buying the shares at $0.93, the Director now owns 10,000 shares.
Before that, Loengard Anna U bought 17,085 shares. Clover Health Investments Corp shares valued at $16,372 were divested by the Director at a price of $0.96 per share. As a result of the transaction, Loengard Anna U now holds 15,600 shares, worth roughly $27612.0.
Cowen upgraded its Clover Health Investments Corp [CLOV] rating to a Market perform from a an Underperform in a research note published on February 02, 2022; the price target was decreased to $3 from $7. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. SVB Leerink began covering CLOV with “Mkt perform” recommendation on January 19, 2022.
Price Performance Review of CLOV
On Monday, Clover Health Investments Corp [NASDAQ:CLOV] saw its stock jump 2.31% to $1.77. Over the last five days, the stock has gained 5.36%. Clover Health Investments Corp shares have risen nearly 85.90% since the year began. Nevertheless, the stocks have risen 62.39% over the past one year. While a 52-week high of $1.78 was reached on 07/29/24, a 52-week low of $0.61 was recorded on 04/22/24. SMA at 50 days reached $1.2596, while 200 days put it at $0.9837. A total of 4.35 million shares were traded, compared to the trading of 3.2 million shares in the previous session.
Levels Of Support And Resistance For CLOV Stock
The 24-hour chart illustrates a support level at 1.7067, which if violated will result in even more drops to 1.6433. On the upside, there is a resistance level at 1.8267. A further resistance level may holdings at 1.8833. The Relative Strength Index (RSI) on the 14-day chart is 72.24, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0890, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 9.80%. Stochastics%K at 84.11% indicates the stock is a selling.
